Brendan Hannah
Directeur Financier/CFO chez QUINCE THERAPEUTICS, INC.
Fortune : 265 344 $ au 30/04/2024
Postes actifs de Brendan Hannah
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
| QUINCE THERAPEUTICS, INC. | Comptroller/Controller/Auditor | 16/03/2023 | - |
| Directeur des opérations | 24/10/2023 | - | |
| Directeur Financier/CFO | 16/03/2023 | - | |
| Corporate Officer/Principal | 01/05/2022 | 16/03/2023 | |
Novosteo, Inc.
 Novosteo, Inc. Pharmaceuticals: MajorHealth Technology Novosteo, Inc. develops drug to reduce complications from a broken bone. The company was founded by Stewart A. Low and Philips S. Low in 2017 and is headquartered in West Lafayette, IN. | Directeur des opérations | - | - |
Historique de carrière de Brendan Hannah
Anciens postes connus de Brendan Hannah
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
| CIDARA THERAPEUTICS, INC. | Corporate Officer/Principal | - | 01/12/2016 |
Neuroptika, Inc.
 Neuroptika, Inc. Pharmaceuticals: MajorHealth Technology Neuroptika, Inc. operates as biotechnology company which develops drugs for eye diseases and nerves regeneration. The company was founded by Chiho Fukiage and in November 2018 and is headquartered in Cambridge, MA. | Corporate Officer/Principal | - | - |
Formation de Brendan Hannah
| University of California | Masters Business Admin |
Statistiques
Internationale
| Etats-Unis | 6 |
Opérationnelle
| Corporate Officer/Principal | 3 |
| Chief Operating Officer | 2 |
| Comptroller/Controller/Auditor | 1 |
Sectorielle
| Health Technology | 5 |
| Consumer Services | 2 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
| Sociétés cotées | 2 |
|---|---|
| QUINCE THERAPEUTICS, INC. | Health Technology |
| CIDARA THERAPEUTICS, INC. | Health Technology |
| Entreprise privées | 2 |
|---|---|
Novosteo, Inc.
Novosteo, Inc. Pharmaceuticals: MajorHealth Technology Novosteo, Inc. develops drug to reduce complications from a broken bone. The company was founded by Stewart A. Low and Philips S. Low in 2017 and is headquartered in West Lafayette, IN. | Health Technology |
Neuroptika, Inc.
Neuroptika, Inc. Pharmaceuticals: MajorHealth Technology Neuroptika, Inc. operates as biotechnology company which develops drugs for eye diseases and nerves regeneration. The company was founded by Chiho Fukiage and in November 2018 and is headquartered in Cambridge, MA. | Health Technology |
- Bourse
- Insiders
- Brendan Hannah
- Expérience
